Frequently asked questions

It depends on the peptide and how it is sold. FDA-approved peptide drugs are legal with a prescription. Compounded peptides are legal only if the ingredient meets 503A or 503B rules ¹. As of October 2026, no "wellness" peptide such as BPC-157 had been added to the 503A bulks list, though FDA advisors recommended six in July 2026 and an interim access policy was under White House review ²³⁴. Selling unapproved peptides for human use, even under a "research only" label, violates federal drug law in FDA's view ⁵.

No. Steroids are fat-soluble molecules built on a four-ring carbon skeleton; peptides are chains of amino acids. Anabolic steroids are federal Schedule III controlled substances, while most peptides are not scheduled ¹⁵. Some peptides do affect hormones (for example by raising growth hormone or testosterone), which is why many are banned in sport ⁷.

Standard workplace drug panels test for drugs of abuse (such as opioids, amphetamines and cannabis) and generally do not look for peptides. Anti-doping labs, however, do test for many peptides and their effects, and WADA prohibits substances such as BPC-157, GH secretagogues, GHRH analogs and TB-500 at all times ⁷. Mislabeled products can also contain unexpected substances ¹³.

Both are once-weekly injectable peptide drugs for type 2 diabetes and (under different brand names) weight management. Semaglutide activates the GLP-1 receptor only. Tirzepatide activates both the GIP and GLP-1 receptors and was the first dual agonist approved, in May 2022 ⁸. Head-to-head trials have generally shown greater average weight loss with tirzepatide, but side effects (mainly gastrointestinal) and suitability vary by person.

Its safety in humans has not been established. Nearly all research is in animals or cells; the human evidence is limited to a few small or unpublished studies, including a two-person IV pilot ⁹. FDA has cited immunogenicity risk, impurity concerns and a lack of safety data ¹⁰, and some researchers raise theoretical concerns about its pro-angiogenic effects and tumor growth ⁹. An FDA advisory committee narrowly voted 8-6 in July 2026 to recommend it for compounding for ulcerative colitis, against FDA staff advice; that vote is not an approval ³².

It means a product is meant for laboratory research, not for people or animals. It is not a legal loophole: FDA warning letters in 2026 rejected RUO disclaimers when sellers made health claims, sold bacteriostatic water, or offered dosing calculators ⁵⁶. RUO products also are not made or tested to pharmaceutical standards.

Usually not effectively. Digestive enzymes break peptide bonds and the gut absorbs intact peptides poorly, so oral bioavailability of most peptides is very low ¹¹. A few exceptions exist, such as oral semaglutide (formulated with an absorption enhancer) and some cyclic peptides. Be skeptical of oral or topical products claiming injection-level effects without human data.

No. Compounded drugs are not FDA-approved and are not reviewed for safety, effectiveness or quality before sale. After the GLP-1 shortages ended in early 2025, FDA ended the period during which compounders could make copies of semaglutide and tirzepatide ¹⁷¹⁸.

In April 2026, FDA removed 12 peptides from its Category 2 "significant safety risk" list after nominations were withdrawn ¹⁶. In July 2026 its advisory committee recommended six (BPC-157, KPV, TB-500, MOTs-C, epitalon, semax) and rejected emideltide (DSIP) ³. In October 2026 an interim access policy went to the White House for review ⁴. None of these steps made the peptides FDA-approved ².

Collagen peptides sold as food supplements are digested into amino acids and small fragments like other dietary protein. They are regulated as foods or supplements, not drugs, and are very different from injectable signaling peptides designed to act on specific receptors.

You often cannot. Studies of online products have found wrong ingredients, very low purity, and endotoxin contamination ¹²¹³. A lot-specific certificate of analysis with mass-spec identity, HPLC purity and endotoxin data, verified with an independent lab, helps, but does not guarantee sterility or safety. Licensed pharmacies dispensing FDA-approved products are the most reliable source.

There is no good evidence that most peptides cause cancer, but there is also little long-term data. Peptides that raise growth hormone and IGF-1 or promote blood-vessel growth raise theoretical concerns about feeding existing tumors ⁹, and FDA notes case reports of melanoma with Melanotan II ¹⁰. People with a cancer history should consult their oncologist.

Many are. WADA's 2026 list prohibits non-approved substances like BPC-157 (S0), growth hormone releasers and growth factors including TB-500 and IGF-1 (S2), and metabolic modulators such as MOTS-c (S4) at all times ⁷.

It depends on the peptide. Injection-site reactions are common across injectables; GLP-1 drugs commonly cause nausea and other gastrointestinal effects; GH-axis peptides can cause water retention and raised blood sugar. Unregulated products add risks from contamination and immune reactions ¹⁰¹².

Seek medical care first if symptoms are serious. Then report the reaction and product to FDA MedWatch at https://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program ¹⁴. In the U.S., Poison Help is 1-800-222-1222.